Table 4. Treatment regimens and response assessment at the point of PB sampling.
Treated WM (N = 33) N (%) |
|||
---|---|---|---|
Treatment regimen | Rituximab containing | 28 | (84.8) |
Total number of previous treatment regimens | 1 | 15 | (45.4) |
2 | 11 | (33.3) | |
> = 3 | 5 | (15.2) | |
Response assessment at PB sampling | CR | 4 | (12.1) |
PR | 21 | (63.6) | |
MR | 3 | (9.1) | |
SD+PD | 3 | (9.1) | |
Not evaluated | 2 | (6.1) |